These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20419882)

  • 1. [Thrombosis of pharmacoactive coronary endoprothesis after stopping antiplatelet treatment].
    Saidi Y; Guesmi F; Landolsi M; Trabelsi S; Khemiri K; Ounalli K; Dziri C; Houissa M
    Tunis Med; 2010 Jan; 88(1):63-4. PubMed ID: 20419882
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
    Baber U; Akhter M; Kothari S; Sharma SK; Kini A
    J Invasive Cardiol; 2010 Feb; 22(2):80-3. PubMed ID: 20124594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
    Chhatriwalla AK; Bhatt DL
    Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
    [No Abstract]   [Full Text] [Related]  

  • 4. Which patients receiving warfarin can be treated safely with a drug-eluting stent?
    Ryding AD; Banning AP
    Heart; 2008 Mar; 94(3):275-7. PubMed ID: 18276815
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.
    Mohammad RA; Goldberg T; Dorsch MP; Cheng JW
    Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-eluting stents can increase the risk of late stent thrombosis].
    Skyttberg N; Linder R; Carlsson J
    Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2845-7. PubMed ID: 17128916
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy.
    Balbi M; Fedele M; Bezante GP; Brunelli C; Barsotti A
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):839-42. PubMed ID: 20216229
    [No Abstract]   [Full Text] [Related]  

  • 8. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
    Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A current problem in cardiology: very late thrombosis after implantation of sirolimus eluting stent.
    Sharifkazemi MB; Zamirian M; Aslani A
    Cardiology; 2007; 108(4):273-4. PubMed ID: 17114881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
    Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticlopidine and aspirin therapy following implantation of coronary artery stents.
    Hobson AG; Sowinski KM
    Ann Pharmacother; 1997 Jun; 31(6):770-2. PubMed ID: 9184720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute coronary stent thrombosis in a patient with angina treated with double antiplatelet drugs for six days.
    Xue F; Yang XJ; Cheng XJ; Hui J; Jiang TB; Chen T; Liu ZH; Song JP; Jiang WP
    Chin Med J (Engl); 2009 Oct; 122(19):2394-5. PubMed ID: 20079146
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.
    Moussa ID; Colombo A
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1047-54. PubMed ID: 19626692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What should one pay attention to during surgery shortly after brachytherapy with coated stents?].
    Schneider C
    Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1586. PubMed ID: 15243911
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronary stents and noncardiac surgery.
    Riddell JW; Chiche L; Plaud B; Hamon M
    Circulation; 2007 Oct; 116(16):e378-82. PubMed ID: 17938292
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailored medical and interventional therapy against recurrent stent thrombosis after drug-eluting stenting.
    Campo G; Valgimigli M; Carrescia C; Carletti R; Ferrari R
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):591-3. PubMed ID: 19520678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed combination dual antiplatelet therapy and the risk of stent thrombosis.
    Davlouros P; Gkizas V; Deftereos S; Giannopoulos G; Alexopoulos D
    Int J Cardiol; 2014 Jun; 174(2):e79-80. PubMed ID: 24794961
    [No Abstract]   [Full Text] [Related]  

  • 19. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
    Wallén H; Agren A; Nekludov M
    Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
    [No Abstract]   [Full Text] [Related]  

  • 20. [After coronary intervention. Which platelet inhibitor for whom?].
    Stiefelhagen P
    MMW Fortschr Med; 2007 Apr; 149(14):18-9. PubMed ID: 17668756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.